Likely To Be Dazed And Confused – An Update

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Regular readers will recall that in March we blogged about cannabis-related trademarks. We now have an update:
United States Intellectual Property

Regular readers will recall that in March we blogged about cannabis-related trademarks. We now have an update:

On May 2, 2019, the USPTO distributed an Examination Guide updating their practices after passage of the 2018 Farm Bill on December 20, 2018. The Farm Bill removes "hemp" from the definition of "marijuana" in the Controlled Substances Act (CSA), so now hemp-based products, like CBD, with less than 0.3% THC are no longer controlled substances. Accordingly, for applications filed after December 20, 2018, the USPTO will not refuse applications on the basis of the goods being unlawful under federal law if the application covers hemp-related goods and services now legal under the CSA. If an application filed before December 20, 2018 for the applicable goods was refused but the application is still pending, the USPTO will allow the applicant to amend its filing date. Applicants should also note that some CBD products that are undergoing FDA testing are still unlawful under the CSA, and therefore applications covering those types of goods will still be refused. If these guidelines apply to you, you can find more information in the Examination Guide from the USPTO, available at the link above.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More